Skip to content

Solstice Advanced Materials Inc. SOLS Product loans payable, noncurrent

Product loans payable, noncurrent at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$531.72M-0.7%
US Physical Therapy logo
US Physical TherapyUSPH
$118.97M-7.7%
Aebi Schmidt Holding AG Common Stock logo
Aebi Schmidt Holding AG Common StockAEBI
$58.21M
Lightpath Technologies logo
Lightpath TechnologiesLPTH
$103.66K-97.8%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$14.99M-66.6%
Floor & Decor logo
Floor & DecorFND
$0-100%

Other financials

Income statement

See full
Revenue$991.0M+10.5%
Gross profit$316.0M-1.3%
Net income$85.0M-36.6%
EPS (diluted)$0.53-37.6%

Balance sheet

See full
Cash & equivalents$642.0M-3.9%
Total debt$2.2B
Total equity$1.5B-54.0%
Total assets$5.7B

Cash flow

See full
Operating cash flow$199.0M+24.4%
CapEx$75.0M+21.0%
Free cash flow$124.0M+26.5%

Valuation

See full
Market cap$13.13B+83.6%
Enterprise value$14.72B
P/E69.9×
P/S3.3×

Profitability

See full
Gross margin31.3%
Net margin4.7%
FCF margin12.6%

Returns & leverage

See full
Return on equity8%
Debt / equity1.5×
Current ratio1.4×

Where this comes from

Reported directly by Solstice Advanced Materials Inc. in its filing.

Tagged under the XBRL concept sols:ProductLoansPayableNoncurrent.

The official record: Solstice Advanced Materials Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solstice Advanced Materials Inc. 's product loans payable, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solstice Advanced Materials Inc. 's product loans payable, noncurrent?
Solstice Advanced Materials Inc. (SOLS) reported product loans payable, noncurrent of $16M in Q1 2026.
What does product loans payable, noncurrent mean?
This represents long-term debt obligations specifically tied to product financing or related capital structures that are due after more than one year. It reflects the company's reliance on long-term leverage to fund its product-related business activities. Investors monitor this to evaluate the company's long-term debt burden and interest rate risk exposure.